News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IPO Watch: Molecular Insight Pharmaceuticals, Inc. (MIPI) Seeks Imaging And Radiotherapeutic Drugs



2/2/2007 6:52:34 PM

February 2, 2007 – Molecular Insight Pharmaceuticals placed 5 million shares with investors at $14 each in its IPO. Although $14 was the low end of the range, the more important fact is that the range held, and a $14 price gives the company a stout $344 million market capitalization. Clearly, investors see potential in Molecular Insight, because its clinical candidates are not particularly advanced. At the moment, it has three compounds in clinical trials, two in Phase II tests, the other in Phase I. We look at the compounds in clinical development and at the finances of the company...



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES